tradingkey.logo

LifeMD Inc

LFMD
查看詳細走勢圖
3.250USD
+0.020+0.62%
交易中 美東報價延遲15分鐘
151.40M總市值
虧損本益比TTM

LifeMD Inc

3.250
+0.020+0.62%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.62%

5天

-4.41%

1月

-15.58%

6月

-77.98%

今年開始到現在

-34.34%

1年

-35.52%

查看詳細走勢圖

TradingKey LifeMD Inc股票評分

單位: USD 更新時間: 2025-12-19

操作建議

LifeMD Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名78/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價9.25。中期看,股價處於下降通道。近一個月,市場表現非常差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

LifeMD Inc評分

相關信息

行業排名
78 / 208
全市場排名
190 / 4582
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 8 分析師
買入
評級
9.250
目標均價
+154.12%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

LifeMD Inc亮點

亮點風險
LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
業績高增長
公司營業收入穩步增長,連續3年增長78.48%
估值合理
公司最新PE估值-12.83,處於3年歷史合理位
機構加倉
最新機構持股24.14M股,環比增加10.27%
PRFDX持倉
明星投資者PRFDX持倉,最新持倉3.48K股
活躍度增加
近期活躍度增加,過去20天平均換手率1.53

LifeMD Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

LifeMD Inc簡介

LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
公司代碼LFMD
公司LifeMD Inc
CEOSchreiber (Justin)
網址https://lifemd.com/

常見問題

LifeMD Inc(LFMD)的當前股價是多少?

LifeMD Inc(LFMD)的當前股價是 3.250。

LifeMD Inc 的股票代碼是什麼?

LifeMD Inc的股票代碼是LFMD。

LifeMD Inc股票的52週最高點是多少?

LifeMD Inc股票的52週最高點是15.840。

LifeMD Inc股票的52週最低點是多少?

LifeMD Inc股票的52週最低點是3.250。

LifeMD Inc的市值是多少?

LifeMD Inc的市值是151.40M。

LifeMD Inc的淨利潤是多少?

LifeMD Inc的淨利潤為-21.99M。

現在LifeMD Inc(LFMD)的股票是買入、持有還是賣出?

根據分析師評級,LifeMD Inc(LFMD)的總體評級為買入,目標價格為9.250。

LifeMD Inc(LFMD)股票的每股收益(EPS TTM)是多少

LifeMD Inc(LFMD)股票的每股收益(EPS TTM)是-0.252。
KeyAI